Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts

The survival rate among children with relapsed neuroblastomas continues to be poor, and thus new therapeutic approaches identified by reliable preclinical drug testing models are urgently needed. Zebrafish are a powerful vertebrate model in preclinical cancer research. Here, we describe a zebrafish...

Full description

Saved in:
Bibliographic Details
Main Authors: Wrobel, Jagoda (Author) , Najafi, Sara (Author) , Ayhan, Simay (Author) , Gatzweiler, Charlotte (Author) , Krunic, Damir (Author) , Ridinger, Johannes (Author) , Milde, Till (Author) , Westermann, Frank (Author) , Peterziel, Heike (Author) , Meder, Benjamin (Author) , Distel, Martin (Author) , Witt, Olaf (Author) , Oehme, Ina (Author)
Format: Article (Journal)
Language:English
Published: 27 October 2020
In: Pharmaceuticals
Year: 2020, Volume: 13, Issue: 11
ISSN:1424-8247
DOI:10.3390/ph13110345
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/ph13110345
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1424-8247/13/11/345
Get full text
Author Notes:Jagoda K. Wrobel, Sara Najafi, Simay Ayhan, Charlotte Gatzweiler, Damir Krunic, Johannes Ridinger, Till Milde, Frank Westermann, Heike Peterziel, Benjamin Meder, Martin Distel, Olaf Witt and Ina Oehme

MARC

LEADER 00000caa a2200000 c 4500
001 1747211621
003 DE-627
005 20220819094018.0
007 cr uuu---uuuuu
008 210203s2020 xx |||||o 00| ||eng c
024 7 |a 10.3390/ph13110345  |2 doi 
035 |a (DE-627)1747211621 
035 |a (DE-599)KXP1747211621 
035 |a (OCoLC)1341390267 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wrobel, Jagoda  |e VerfasserIn  |0 (DE-588)1226258093  |0 (DE-627)1747213098  |4 aut 
245 1 0 |a Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts  |c Jagoda K. Wrobel, Sara Najafi, Simay Ayhan, Charlotte Gatzweiler, Damir Krunic, Johannes Ridinger, Till Milde, Frank Westermann, Heike Peterziel, Benjamin Meder, Martin Distel, Olaf Witt and Ina Oehme 
264 1 |c 27 October 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.02.2021 
520 |a The survival rate among children with relapsed neuroblastomas continues to be poor, and thus new therapeutic approaches identified by reliable preclinical drug testing models are urgently needed. Zebrafish are a powerful vertebrate model in preclinical cancer research. Here, we describe a zebrafish neuroblastoma yolk sac model to evaluate efficacy and toxicity of histone deacetylase (HDAC) inhibitor treatments. Larvae were engrafted with fluorescently labeled, genetically diverse, established cell lines and short-term cultures of patient-derived primary cells. Engrafted tumors progressed locally and disseminated remotely in an intact environment. Combination treatments involving the standard chemotherapy doxorubicin and HDAC inhibitors substantially reduced tumor volume, induced tumor cell death, and inhibited tumor cell dissemination to the tail region. Hence, this model allows for fast, cost-efficient, and reliable in vivo evaluation of toxicity and response of the primary and metastatic tumor sites to drug combinations. 
650 4 |a childhood cancer 
650 4 |a histone deacetylases 
650 4 |a precision medicine 
650 4 |a preclinical models 
650 4 |a small molecules 
650 4 |a xenotransplantation 
700 1 |a Najafi, Sara  |d 1983-  |e VerfasserIn  |0 (DE-588)1218816864  |0 (DE-627)1734540451  |4 aut 
700 1 |a Ayhan, Simay  |e VerfasserIn  |0 (DE-588)1226258271  |0 (DE-627)1747213446  |4 aut 
700 1 |a Gatzweiler, Charlotte  |e VerfasserIn  |4 aut 
700 1 |a Krunic, Damir  |e VerfasserIn  |0 (DE-588)134233565  |0 (DE-627)564819743  |0 (DE-576)300392893  |4 aut 
700 1 |a Ridinger, Johannes  |e VerfasserIn  |0 (DE-588)1162237341  |0 (DE-627)1025709357  |0 (DE-576)507290496  |4 aut 
700 1 |a Milde, Till  |d 1973-  |e VerfasserIn  |0 (DE-588)1038311837  |0 (DE-627)75711234X  |0 (DE-576)39229334X  |4 aut 
700 1 |a Westermann, Frank  |d 1968-  |e VerfasserIn  |0 (DE-588)118119990  |0 (DE-627)69468628X  |0 (DE-576)291725570  |4 aut 
700 1 |a Peterziel, Heike  |e VerfasserIn  |0 (DE-588)1079032606  |0 (DE-627)840098022  |0 (DE-576)452152348  |4 aut 
700 1 |a Meder, Benjamin  |e VerfasserIn  |0 (DE-588)135821630  |0 (DE-627)571676316  |0 (DE-576)300664745  |4 aut 
700 1 |a Distel, Martin  |e VerfasserIn  |4 aut 
700 1 |a Witt, Olaf  |d 1965-  |e VerfasserIn  |0 (DE-588)17275030X  |0 (DE-627)697681750  |0 (DE-576)133607410  |4 aut 
700 1 |a Oehme, Ina  |d 1974-  |e VerfasserIn  |0 (DE-588)129573388  |0 (DE-627)473352621  |0 (DE-576)297728652  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceuticals  |d Basel : MDPI, 2004  |g 13(2020,11) Artikel-Nummer 345, 19 Seiten  |h Online-Ressource  |w (DE-627)491437528  |w (DE-600)2193542-7  |w (DE-576)281279470  |x 1424-8247  |7 nnas  |a Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts 
773 1 8 |g volume:13  |g year:2020  |g number:11  |a Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts 
856 4 0 |u https://doi.org/10.3390/ph13110345  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1424-8247/13/11/345  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210203 
993 |a Article 
994 |a 2020 
998 |g 129573388  |a Oehme, Ina  |m 129573388:Oehme, Ina  |d 50000  |e 50000PO129573388  |k 0/50000/  |p 13  |y j 
998 |g 17275030X  |a Witt, Olaf  |m 17275030X:Witt, Olaf  |d 910000  |d 910500  |d 50000  |e 910000PW17275030X  |e 910500PW17275030X  |e 50000PW17275030X  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 12 
998 |g 135821630  |a Meder, Benjamin  |m 135821630:Meder, Benjamin  |d 910000  |d 910100  |d 50000  |e 910000PM135821630  |e 910100PM135821630  |e 50000PM135821630  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10 
998 |g 1079032606  |a Peterziel, Heike  |m 1079032606:Peterziel, Heike  |d 50000  |e 50000PP1079032606  |k 0/50000/  |p 9 
998 |g 118119990  |a Westermann, Frank  |m 118119990:Westermann, Frank  |d 50000  |e 50000PW118119990  |k 0/50000/  |p 8 
998 |g 1038311837  |a Milde, Till  |m 1038311837:Milde, Till  |d 910000  |d 910500  |d 50000  |e 910000PM1038311837  |e 910500PM1038311837  |e 50000PM1038311837  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 7 
998 |g 1226258271  |a Ayhan, Simay  |m 1226258271:Ayhan, Simay  |d 910000  |d 910500  |e 910000PA1226258271  |e 910500PA1226258271  |k 0/910000/  |k 1/910000/910500/  |p 3 
998 |g 1218816864  |a Najafi, Sara  |m 1218816864:Najafi, Sara  |d 910000  |d 910500  |e 910000PN1218816864  |e 910500PN1218816864  |k 0/910000/  |k 1/910000/910500/  |p 2 
999 |a KXP-PPN1747211621  |e 3848338971 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1747211621","note":["Gesehen am 03.02.2021"],"language":["eng"],"person":[{"display":"Wrobel, Jagoda","given":"Jagoda","role":"aut","roleDisplay":"VerfasserIn","family":"Wrobel"},{"display":"Najafi, Sara","given":"Sara","role":"aut","roleDisplay":"VerfasserIn","family":"Najafi"},{"display":"Ayhan, Simay","given":"Simay","role":"aut","roleDisplay":"VerfasserIn","family":"Ayhan"},{"family":"Gatzweiler","display":"Gatzweiler, Charlotte","roleDisplay":"VerfasserIn","role":"aut","given":"Charlotte"},{"display":"Krunic, Damir","given":"Damir","roleDisplay":"VerfasserIn","role":"aut","family":"Krunic"},{"display":"Ridinger, Johannes","roleDisplay":"VerfasserIn","role":"aut","given":"Johannes","family":"Ridinger"},{"family":"Milde","roleDisplay":"VerfasserIn","role":"aut","given":"Till","display":"Milde, Till"},{"family":"Westermann","given":"Frank","role":"aut","roleDisplay":"VerfasserIn","display":"Westermann, Frank"},{"given":"Heike","roleDisplay":"VerfasserIn","role":"aut","display":"Peterziel, Heike","family":"Peterziel"},{"family":"Meder","display":"Meder, Benjamin","role":"aut","roleDisplay":"VerfasserIn","given":"Benjamin"},{"display":"Distel, Martin","given":"Martin","role":"aut","roleDisplay":"VerfasserIn","family":"Distel"},{"display":"Witt, Olaf","given":"Olaf","roleDisplay":"VerfasserIn","role":"aut","family":"Witt"},{"display":"Oehme, Ina","roleDisplay":"VerfasserIn","role":"aut","given":"Ina","family":"Oehme"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2004 -"],"recId":"491437528","part":{"text":"13(2020,11) Artikel-Nummer 345, 19 Seiten","year":"2020","volume":"13","issue":"11"},"note":["Gesehen am 05.09.2011"],"id":{"eki":["491437528"],"zdb":["2193542-7"],"issn":["1424-8247"]},"disp":"Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenograftsPharmaceuticals","language":["eng"],"name":{"displayForm":["Molecular Diversity Preservation International"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2004","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2004-"}],"title":[{"title_sort":"Pharmaceuticals","title":"Pharmaceuticals"}]}],"name":{"displayForm":["Jagoda K. Wrobel, Sara Najafi, Simay Ayhan, Charlotte Gatzweiler, Damir Krunic, Johannes Ridinger, Till Milde, Frank Westermann, Heike Peterziel, Benjamin Meder, Martin Distel, Olaf Witt and Ina Oehme"]},"id":{"eki":["1747211621"],"doi":["10.3390/ph13110345"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"27 October 2020"}],"title":[{"title":"Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts","title_sort":"Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts"}]} 
SRT |a WROBELJAGORAPIDINVIV2720